These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10573045)

  • 41. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.
    Cullen DJ; Sweitzer BJ; Bates DW; Burdick E; Edmondson A; Leape LL
    Crit Care Med; 1997 Aug; 25(8):1289-97. PubMed ID: 9267940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay.
    Oderda GM; Said Q; Evans RS; Stoddard GJ; Lloyd J; Jackson K; Rublee D; Samore MH
    Ann Pharmacother; 2007 Mar; 41(3):400-6. PubMed ID: 17341537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse drug events in hospitalized cardiac patients.
    Fanikos J; Cina JL; Baroletti S; Fiumara K; Matta L; Goldhaber SZ
    Am J Cardiol; 2007 Nov; 100(9):1465-9. PubMed ID: 17950809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventing adverse drug events in hospitalized patients.
    Evans RS; Pestotnik SL; Classen DC; Horn SD; Bass SB; Burke JP
    Ann Pharmacother; 1994 Apr; 28(4):523-7. PubMed ID: 8038479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential risks and prevention, Part 1: Fatal adverse drug events.
    Kelly WN
    Am J Health Syst Pharm; 2001 Jul; 58(14):1317-24. PubMed ID: 11471479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Adverse Events With Antibiotic Use in Hospitalized Patients.
    Tamma PD; Avdic E; Li DX; Dzintars K; Cosgrove SE
    JAMA Intern Med; 2017 Sep; 177(9):1308-1315. PubMed ID: 28604925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practical approach to determining costs and frequency of adverse drug events in a health care network.
    Senst BL; Achusim LE; Genest RP; Cosentino LA; Ford CC; Little JA; Raybon SJ; Bates DW
    Am J Health Syst Pharm; 2001 Jun; 58(12):1126-32. PubMed ID: 11449856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse drug events in emergency department patients.
    Hafner JW; Belknap SM; Squillante MD; Bucheit KA
    Ann Emerg Med; 2002 Mar; 39(3):258-67. PubMed ID: 11867978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for adverse drug events among nursing home residents.
    Field TS; Gurwitz JH; Avorn J; McCormick D; Jain S; Eckler M; Benser M; Bates DW
    Arch Intern Med; 2001 Jul; 161(13):1629-34. PubMed ID: 11434795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a Computer-Assisted Adverse Drug Events Alarm and Assessment System for Hospital Inpatients in China.
    Chen C; Jia W; Guo D; Zhu M; Xu Y; Wang X; Wang D; Wang W; Tang Z
    Ther Innov Regul Sci; 2020 Jan; 54(1):32-41. PubMed ID: 32008241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of adverse drug events on morbidity and mortality in intensive care units: the JADE study.
    Ohta Y; Sakuma M; Koike K; Bates DW; Morimoto T
    Int J Qual Health Care; 2014 Dec; 26(6):573-8. PubMed ID: 25192926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.
    Overhage JM; Gandhi TK; Hope C; Seger AC; Murray MD; Orav EJ; Bates DW
    J Patient Saf; 2016 Jun; 12(2):69-74. PubMed ID: 26001546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database.
    Poudel DR; Acharya P; Ghimire S; Dhital R; Bharati R
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):635-641. PubMed ID: 28233421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Adverse drug effects observed at French admissions departments and emergency services (Prospective study of the National Educational Association for Teaching Therapeutics and proposals for preventive measures].
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X;
    Bull Acad Natl Med; 2003; 187(4):647-66; discussion 666-70. PubMed ID: 14556474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adverse drug effects: a prospective study by Apnet performed in seven emergency care units in France: propositions for preventive measures].
    Queneau P; Trombert B; Carpentier F; Trinh-Duc A; Bannwarth B; Bouget J;
    Ann Pharm Fr; 2005 Mar; 63(2):131-42. PubMed ID: 15976680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug Use and Type of Adverse Drug Events-Identified by a Trigger Tool in Different Units in a Swedish Pediatric Hospital.
    Nydert P; Unbeck M; Pukk Härenstam K; Norman M; Lindemalm S
    Drug Healthc Patient Saf; 2020; 12():31-40. PubMed ID: 32099481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.
    de Vries ST; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
    Health Qual Life Outcomes; 2014 Aug; 12():103. PubMed ID: 25115618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.